Industry News

Alembic Pharmaceuticals Limited has announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxorubicin Hydrochloride Liposome Injection in two strengths: 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials.

As reported by Reuters, U.S. pharmaceutical giant Eli Lilly has launched its Mounjaro KwikPen in India, expanding its portfolio of treatments for diabetes and obesity.

Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical company, has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its official entry into the immuno-oncology segment.

Emcure Pharmaceuticals has announced that its Board of Directors has approved a proposal to acquire the remaining 20.42% minority stake in its subsidiary, Zuventus Healthcare Ltd. The acquisition will result in Zuventus becoming a wholly owned subsidiary of Emcure.

Fresenius Kabi has issued an urgent nationwide recall of a specific lot of its Ivenix Large-Volume Pump (LVP) Blood Products Administration Sets, following the discovery of a manufacturing defect that could lead to serious or even fatal consequences.

Glenmark Pharmaceuticals Ltd. has announced that the United States Food and Drug Administration (USFDA) has completed a Good Manufacturing Practices (GMP) inspection at its manufacturing facility in Monroe, North Carolina, USA.

The agreement grants RayzeBio exclusive worldwide rights to Philochem’s clinical-stage radiopharmaceutical candidate OncoACP3.

Amneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte.